{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:29:08Z","timestamp":1761625748927,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.dld.2021.11.019","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T07:37:36Z","timestamp":1639381056000},"page":"710-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The need of HVPG-guided beta-blocker therapy for NASH cirrhosis with varices \u2013 Answer is still up in the air"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9626-5243","authenticated-orcid":false,"given":"Suprabhat","family":"Giri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2021.11.019_bib0001","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.11.019_bib0002","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2021.11.019_bib0003","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.dld.2021.09.009","article-title":"The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices","volume":"54","author":"Paternostro","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2021.11.019_bib0004","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/liv.12229","article-title":"Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis","volume":"34","author":"Reverter","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.dld.2021.11.019_bib0005","article-title":"Impact of propofol sedation on the diagnostic accuracy of hepatic venous pressure gradient measurements in patients with cirrhosis","author":"Ebrahimi","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.dld.2021.11.019_bib0006","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MEG.0000000000000825","article-title":"Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis","volume":"29","author":"Sourianarayanane","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.11.019_bib0007","article-title":"Decompensation in advanced non-alcoholic fatty liver disease may occur at lower hepatic venous pressure gradient levels that in patients with viral disease","author":"Bassegoda","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2021.11.019_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128774","article-title":"Prognostic value of non-invasive fibrosis and steatosis tools, hepatic venous pressure gradient and histology in nonalcoholic steatohepatitis","volume":"10","author":"Sebastiani","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.dld.2021.11.019_bib0009","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.jhep.2018.10.018","article-title":"Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices","volume":"70","author":"Kim","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.dld.2021.11.019_bib0010","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s12072-020-10062-w","article-title":"Spleen stiffness measurement for assessing the response to \u03b2-blockers therapy for high-risk esophageal varices patients","volume":"14","author":"Marasco","year":"2020","journal-title":"Hepatol Int"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821008859?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865821008859?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:20:00Z","timestamp":1761625200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865821008859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1590865821008859"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2021.11.019","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The need of HVPG-guided beta-blocker therapy for NASH cirrhosis with varices \u2013 Answer is still up in the air","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2021.09.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}